Enzymotec Stock Price (NASDAQ:ENZY)

Add to My Stocks
$8.25 $0.2 (2.48%) ENZY stock closing price May 24, 2017 (Closing)
YOUR DAILY UPDATE ON
ENZY
Enzymotec
24 MAY 2017
amigobulls logo
ENZY hand_up
ENZY vs S&P 500
Closing Price: May 24, 2017
ENZY
$8.25 ( 2.48%)
S&P 500
2404.4 ( 0.25%)
ENZY
52 Week Price Range
1 Year Return: 0.75%
Q1 Growth*
Poor
Profitable ?
No
net image
2017 Q1 Net Loss
-9.5%
home image
Rating
ENZY AVERAGE
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Enzymotec Snapshot Video

11 5 2

ENZY Stock Details

Prev Close* : $8.05
Market Cap:
$184.71M
Day Low: $8
52 Week Low: $5.20
Open: $8.05
Volume: 2261
Day High: $8.3
52 Week High: $9.32
Dividend:
N/A

Latest Stock Market News

Latest Articles

Enzymotec News - From Partners

ENZY Stockcharts

View ENZY PE ratio, PS ratio stocks charts and compare with peers.
ENZY Chart
Note: Compare Enzymotec stock price history with the index and industry peers.

Enzymotec Valuation

PS ratio (
price to sales ratio
)
4.13
PB ratio (
price to book ratio
)
1.36

Enzymotec Financial Ratios

Asset Turnover
0.28
Receivables Turnover
3.15

ENZY Industry Peers

Company Price Change (%)
Utah Medical Products (UTMD)650.05 (0.08%)
Chimerix (CMRX)4.630.09 (1.91%)
Teva Pharmaceutical (TEVA)28.980.22 (0.76%)
Neptune Tech. & Bio. (NEPT)1.140.01 (0.87%)
Acasti Pharma (ACST)1.260 (0%)
Abbott (ABT)43.530.15 (0.34%)
Sodastream International (SODA)52.10.4 (0.76%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Rockwell Medical (RMTI)7.10.39 (5.81%)
LeMaitre Vascular (LMAT)30.710.97 (3.26%)
Enzymotec (ENZY)8.250.2 (2.48%)
Fonar (FONR)24.50.55 (2.3%)
Insys Therapeutics (INSY)13.420.24 (1.82%)
Omeros (OMER)16.090.24 (1.51%)
Phibro Animal Health (PAHC)35.050.5 (1.45%)
Top gainers from Medical Products industry
* As of May 25, 2017
CompanyPriceChange (%)
Agios Pharma (AGIO)47.241.32 (2.72%)
Oramed Pharma (ORMP)8.390.19 (2.21%)
Chimerix (CMRX)4.630.09 (1.91%)
Cardiovascular Systems (CSII)30.550.55 (1.77%)
Perrigo (PRGO)71.931.14 (1.56%)
GW Pharma (GWPH)106.311.49 (1.38%)
SurModics (SRDX)22.7750.28 (1.21%)
Top losers from Medical Products industry
* As of May 25, 2017

Enzymotec Ltd Stock News - Partner Headlines

Enzymotec Financial Statements

income statement20162015201420132012
Net Sales Or Revenues47.69M50.39M47.1M64.97M37.87M
Net Income-2.92M6.68M7.83M11.39M4.78M
Total Operating Expense33.09M24.57M21.48M21.09M-
view Enzymotec Ltd income statement
balance sheet2016201520142013
Total Assets146.94M148.92M138.25M136.37M
Total Liabilities10.34M12.2M9.97M18.47M
Shareholders Equity136.6M136.71M128.27M117.9M
view Enzymotec Ltd balance sheet
cash flow statement2016201520142013
Net Increase (Decrease) In Assets Liabilities-0.8M1.17M-9.62M-6.17M
Net Cash From (Used By) Operating Activities1.38M11.19M1.96M7.39M
Increase (Decrease) In Prop Plant And Equipment-2.11M-2.85M-6.36M-4.87M
view Enzymotec Ltd cashflow statement

Enzymotec Stock Message Board

Enzymotec stock price ended the last trading day at 8.25. Looking at Enzymotec market capitalization, which currently stands at 184.71M, we can say that ENZY stock is a Micro cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Enzymotec stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Enzymotec is worth a lot, it will most likely be reflected in an inflated Enzymotec stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 2261 ENZY shares were traded yesterday, and Enzymotec stock chart shows that the ENZY stock quote hit a day high of 8.3 and day low of 8. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Enzymotec does not pay dividends. One can observe stock price trends and check for volatility by checking Enzymotec stock price history.